These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

170 related articles for article (PubMed ID: 34206061)

  • 21. Clinicopathologic and Molecular Characteristics of Synchronous Colorectal Carcinoma With Mismatch Repair Deficiency.
    Nakano K; Yamamoto H; Fujiwara M; Koga Y; Tsuruta S; Ihara E; Oki E; Nakamura M; Ogawa Y; Oda Y
    Am J Surg Pathol; 2018 Feb; 42(2):172-182. PubMed ID: 28877066
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Double somatic mutations in mismatch repair genes are frequent in colorectal cancer after Hodgkin's lymphoma treatment.
    Rigter LS; Snaebjornsson P; Rosenberg EH; Atmodimedjo PN; Aleman BM; Ten Hoeve J; Geurts-Giele WR; ; van Ravesteyn TW; Hoeksel J; Meijer GA; Te Riele H; van Leeuwen FE; Dinjens WN; van Leerdam ME
    Gut; 2018 Mar; 67(3):447-455. PubMed ID: 29439113
    [TBL] [Abstract][Full Text] [Related]  

  • 23. No Difference in Colorectal Cancer Incidence or Stage at Detection by Colonoscopy Among 3 Countries With Different Lynch Syndrome Surveillance Policies.
    Engel C; Vasen HF; Seppälä T; Aretz S; Bigirwamungu-Bargeman M; de Boer SY; Bucksch K; Büttner R; Holinski-Feder E; Holzapfel S; Hüneburg R; Jacobs MAJM; Järvinen H; Kloor M; von Knebel Doeberitz M; Koornstra JJ; van Kouwen M; Langers AM; van de Meeberg PC; Morak M; Möslein G; Nagengast FM; Pylvänäinen K; Rahner N; Renkonen-Sinisalo L; Sanduleanu S; Schackert HK; Schmiegel W; Schulmann K; Steinke-Lange V; Strassburg CP; Vecht J; Verhulst ML; de Vos Tot Nederveen Cappel W; Zachariae S; Mecklin JP; Loeffler M;
    Gastroenterology; 2018 Nov; 155(5):1400-1409.e2. PubMed ID: 30063918
    [TBL] [Abstract][Full Text] [Related]  

  • 24. A simple model for carcinogenesis of colorectal cancers with microsatellite instability.
    Janin N
    Adv Cancer Res; 2000; 77():189-221. PubMed ID: 10549359
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Mathematical modeling of multiple pathways in colorectal carcinogenesis using dynamical systems with Kronecker structure.
    Haupt S; Zeilmann A; Ahadova A; Bläker H; von Knebel Doeberitz M; Kloor M; Heuveline V
    PLoS Comput Biol; 2021 May; 17(5):e1008970. PubMed ID: 34003820
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [Familial colorectal cancer type X: clinical, pathological and molecular characterization].
    Ferreira S; Lage P; Sousa R; Claro I; Francisco I; Filipe B; Suspiro A; Chaves P; Rodrigues P; Albuquerque C; Nobre Leitão C
    Acta Med Port; 2009; 22(3):207-14. PubMed ID: 19686620
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Prevalence of mismatch repair-deficient crypt foci in Lynch syndrome: a pathological study.
    Kloor M; Huth C; Voigt AY; Benner A; Schirmacher P; von Knebel Doeberitz M; Bläker H
    Lancet Oncol; 2012 Jun; 13(6):598-606. PubMed ID: 22552011
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Activating ERBB2/HER2 mutations indicate susceptibility to pan-HER inhibitors in Lynch and Lynch-like colorectal cancer.
    Kloth M; Ruesseler V; Engel C; Koenig K; Peifer M; Mariotti E; Kuenstlinger H; Florin A; Rommerscheidt-Fuss U; Koitzsch U; Wodtke C; Ueckeroth F; Holzapfel S; Aretz S; Propping P; Loeffler M; Merkelbach-Bruse S; Odenthal M; Friedrichs N; Heukamp LC; Zander T; Buettner R
    Gut; 2016 Aug; 65(8):1296-305. PubMed ID: 26001389
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Molecular testing for Lynch syndrome in people with colorectal cancer: systematic reviews and economic evaluation.
    Snowsill T; Coelho H; Huxley N; Jones-Hughes T; Briscoe S; Frayling IM; Hyde C
    Health Technol Assess; 2017 Sep; 21(51):1-238. PubMed ID: 28895526
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Frameshift mutational target gene analysis identifies similarities and differences in constitutional mismatch repair-deficiency and Lynch syndrome.
    Maletzki C; Huehns M; Bauer I; Ripperger T; Mork MM; Vilar E; Klöcking S; Zettl H; Prall F; Linnebacher M
    Mol Carcinog; 2017 Jul; 56(7):1753-1764. PubMed ID: 28218421
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Metachronous colorectal cancer risk in Lynch syndrome patients-should the endoscopic surveillance be more intensive?
    Anyla M; Lefevre JH; Creavin B; Colas C; Svrcek M; Lascols O; Debove C; Chafai N; Tiret E; Parc Y
    Int J Colorectal Dis; 2018 Jun; 33(6):703-708. PubMed ID: 29532206
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Comparison of screening strategies for Lynch syndrome in patients with newly diagnosed endometrial cancer: a prospective cohort study in China.
    Chao X; Li L; Wu M; Ma S; Tan X; Zhong S; Bi Y; Lang J
    Cancer Commun (Lond); 2019 Jul; 39(1):42. PubMed ID: 31307542
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Clinical Aspects of Microsatellite Instability Testing in Colorectal Cancer.
    Zeinalian M; Hashemzadeh-Chaleshtori M; Salehi R; Emami MH
    Adv Biomed Res; 2018; 7():28. PubMed ID: 29531926
    [TBL] [Abstract][Full Text] [Related]  

  • 34. The spectrum of Lynch syndrome-associated germ-line mutations in Russia.
    Yanus GA; Akhapkina TA; Iyevleva AG; Kornilov AV; Suspitsin EN; Kuligina ES; Ivantsov AO; Aleksakhina SN; Sokolova TN; Sokolenko AP; Togo AV; Imyanitov EN
    Eur J Med Genet; 2020 Mar; 63(3):103753. PubMed ID: 31491536
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Metachronous serrated neoplasia is uncommon after right colectomy in patients with methylator colon cancers with a high degree of microsatellite instability.
    Messick CA; Kravochuck S; Church JM; Kalady MF
    Dis Colon Rectum; 2014 Jan; 57(1):39-46. PubMed ID: 24316944
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Combined Microsatellite Instability, MLH1 Methylation Analysis, and Immunohistochemistry for Lynch Syndrome Screening in Endometrial Cancers From GOG210: An NRG Oncology and Gynecologic Oncology Group Study.
    Goodfellow PJ; Billingsley CC; Lankes HA; Ali S; Cohn DE; Broaddus RJ; Ramirez N; Pritchard CC; Hampel H; Chassen AS; Simmons LV; Schmidt AP; Gao F; Brinton LA; Backes F; Landrum LM; Geller MA; DiSilvestro PA; Pearl ML; Lele SB; Powell MA; Zaino RJ; Mutch D
    J Clin Oncol; 2015 Dec; 33(36):4301-8. PubMed ID: 26552419
    [TBL] [Abstract][Full Text] [Related]  

  • 37. What is the appropriate screening protocol in Lynch syndrome?
    de Jong AE; Nagengast FM; Kleibeuker JH; van de Meeberg PC; van Wijk HJ; Cats A; Griffioen G; Vasen HF
    Fam Cancer; 2006; 5(4):373-8. PubMed ID: 16826316
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Endoscopic surveillance of Lynch syndrome at a highly specialized center in Sweden: An observational study of interval colorectal cancer and individual risk factors.
    Jamizadeh N; Walton Bernstedt S; Haxhijaj A; Andreasson A; Björk J; Forsberg A; Backman AS
    Front Oncol; 2023; 13():1127707. PubMed ID: 36890827
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Assessment of Tumor Sequencing as a Replacement for Lynch Syndrome Screening and Current Molecular Tests for Patients With Colorectal Cancer.
    Hampel H; Pearlman R; Beightol M; Zhao W; Jones D; Frankel WL; Goodfellow PJ; Yilmaz A; Miller K; Bacher J; Jacobson A; Paskett E; Shields PG; Goldberg RM; de la Chapelle A; Shirts BH; Pritchard CC;
    JAMA Oncol; 2018 Jun; 4(6):806-813. PubMed ID: 29596542
    [TBL] [Abstract][Full Text] [Related]  

  • 40. DNA mismatch repair deficiency in sporadic colorectal cancer and Lynch syndrome.
    Poulogiannis G; Frayling IM; Arends MJ
    Histopathology; 2010 Jan; 56(2):167-79. PubMed ID: 20102395
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.